Day: April 22, 2014

Hemophilia Patients Urge NIH & IRB To Stop Ineffective Hepatitis C Trial

Below is a letter from People with Bleeding Disorders and HCV to the Institutional Review Board (IRB) and National Heart, Lung, and Blood Institute (NIH) office recommending to end recruitment of a clinical study (pINF+RIBA+Telaprevir).  People with Bleeding Disorders feel that this study is out-dated and mediocre therapy for Hepatitis C (HCV). To: Institutional Review Board, University of […]